Alcohol related liver disease accounts for 50% of all liver disease, but the biology of why some individuals develop severe liver disease (cirrhosis) and other do not, remains uncertain, and management options remain exceedingly limited and centered around abstinence. In this series, we seek to address these knowledge and care gaps by highlighting state of the art knowledge and bringing together clinicians and investigators in a virtual forum. This will be a once monthly virtual seminar, featuring global experts in hepatology, addiction medicine and the basic science of liver disease to highlight state-of-the-art knowledge and an evidenced-based approach to the diagnosis and management of alcohol-related liver disease.